Company profile for Durect Corporation

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

DURECT is a biopharmaceutical company focused on the development of medicines that provide meaningful advances in patient health and wellbeing. An endogenous, orally bioavailable small molecule in development for chronic liver disease and acute organ injury. DURECT is focusing its efforts on therapeutic areas with significant unmet need, including diseases with no approved treatments like alcoholic hepatitis (AH) and non-alcoh...
DURECT is a biopharmaceutical company focused on the development of medicines that provide meaningful advances in patient health and wellbeing. An endogenous, orally bioavailable small molecule in development for chronic liver disease and acute organ injury. DURECT is focusing its efforts on therapeutic areas with significant unmet need, including diseases with no approved treatments like alcoholic hepatitis (AH) and non-alcoholic steatohepatitis (NASH).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
DURECT Corporation 10260 Bubb Road Cupertino, CA
Telephone
Telephone
408-777-1417
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bausch-health-completes-acquisition-of-durect-corporation-expanding-l-1071552

ACCESSWIRE
11 Sep 2025

https://www.pharmiweb.com/press-release/2025-08-26/bausch-health-announces-extension-of-durect-corporation-tender-offer-to-september-10-2025

PHARMAWEB
26 Aug 2025

https://www.prnewswire.com/news-releases/durect-corporation-reports-second-quarter-2025-financial-results-and-provides-update-on-proposed-acquisition-by-bausch-health-302528122.html

PR NEWSWIRE
12 Aug 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bausch-health-to-acquire-durect-corporation-strengthening-commitment-1054168

ACCESSWIRE
30 Jul 2025

https://www.prnewswire.com/news-releases/durect-corporation-reports-first-quarter-2025-financial-results-and-provides-business-update-302454355.html

PR NEWSWIRE
13 May 2025

https://www.prnewswire.com/news-releases/durect-corporation-reports-fourth-quarter-and-full-year-2024-financial-results-and-provides-business-update-302412442.html

PR NEWSWIRE
26 Mar 2025

Excipients

Click here to find the perfect excipient manufacturers by their capabilities

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Contact Durect Corporation and get a quotation

Durect Corporation is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Larsucosterol bulk with DMF offered by Durect Corporation

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty